Paper - WANFANG MED ONLINE

You Position: Home > Paper

Childhood non-Hodgkin lymphoma

( views:252, downloads:186 )

Author:: No author available

Journal Title:: JOURNAL OF LEUKEMIA & LYMPHOMA

Issue:: 1

DOI:: 10.3760/cma.j.issn.1009-9921.2008.01.004

Key Word:: 淋巴瘤,非霍奇金;儿童

Abstract：概述了儿童非霍奇金淋巴瘤(NHL)的病因及发病机制的研究进展,介绍了WHO 2001年儿童NHL的病理分型以及不同病理类型的临床特点,提出了针对不同病理类型、不同危险因素进行分层治疗的治疗理念并推荐了几套疗效较好的与国际接轨的方案,对儿童淋巴瘤今后的研究和治疗趋势进行了展望.

Reference

[1]David A, Thorley-Lawson,Andrew, Gross.Persistence of the Epstein-Barr virus and the origins of associated lymphomas.[J].2004,350(13).
[2]Kieron, Dunleavy,R Eric, Davis,Ola, Landgren,etc.BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?[J].2007,109(2).
[3]Yamada Y,Zhong Y,Jiang L,etc.Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.[J].2007,26(48).
[4]D, BURKITT.A sarcoma involving the jaws in African children.[J].1958,46(197).
[5]I T, Magrath.Non-Hodgkin's lymphomas: epidemiology and treatment.[J].1997,824.
[6]Lin YW,Aplan PD.Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.[J].2007,21(6).
[7]Yasodha, Natkunam,Shuchun, Zhao,David Y, Mason,etc.The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.[J].2007,109(4).
[8]Weng AP,Millholland JM,Yashiro Ohtani Y,etc.c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.[J].2006,20(15).
[9]Christina, Spaulding,Erica J, Reschly,Derek E, Zagort,etc.Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.[J].2007,110(7).
[10]Tarbell N,Kepner J,Weitzman S,etc.Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tria[J].2005,23(3).
[11]Paola, Ballerini,Annick, Blaise,Maryvonne, Busson-Le Coniat,etc.HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.[J].2002,100(3).
[12]B U, Mueller.Cancers in children infected with the human immunodeficiency virus.[J].1999,4(4).
[13]Tsuchiya T,Kanda M,Suzumiya J,etc.Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.[J].2001,42(5).
[14]Hélène, Cavé,Stefan, Suciu,Claude, Preudhomme,etc.Clinical significance of HOX11L2 expression linked to t(5; 14)(q35; q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.[J].2004,103(2).
[15]Kikuchi M,Muta H,Ohshima K,etc.Prognostic value of Bcl 10 rearrangement in diffuse large B-cell lymphoma.[J].2002,43(4).
[16]R C, Ribeiro,C H, Pui,S B, Murphy,etc.Childhood malignant non-Hodgkin lymphomas of uncommon histology.[J].1992,6(8).
[17]Rashford Michelle,Benyunes Mark,Grillo Lopez AntonioJ,etc.Rituximab: ongoing and future clinical development.[J].2002,29(1 Suppl.2).
[18]Mark A, Lones,Nyla A, Heerema,Michelle M, Le Beau,etc.Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.[J].2007,172(1).
[19]Damotte D,Amouroux I,Flandrin G,etc.Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.[J].2006,47(9).
[20]Hesham M, Amin,Raymond, Lai.Pathobiology of ALK+ anaplastic large-cell lymphoma.[J].2007,110(7).
[21]Staudt LM,Wilson WH,Dunleavy K.The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.[J].2007,48(6).
[22]Takino H,Eimoto T,Li C,etc.Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.[J].2007,20(6).
[23]Dube ID,Kwon YT,Chen E,etc.Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.[J].2006,25(42).
[24]Hobson R,Ng A,Williams D,etc.Anaplastic large cell lymphoma of bone--is it a bad tumor?[J].2007,48(4).
[25]Novosel A,Keller T,Wiemels J,etc.Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8; 14) translocations in sporadic Burkitt-lymphoma.[J].2007,21(8).
[26]A, Reiter,M, Schrappe,W D, Ludwig,etc.Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.[J].2000,95(2).